Skip to main content

Table 5 Demographic characteristics and changes in the features pertaining to OCTA images after aflibercept treatment in patients with myopic CNV

From: Result of intravitreal aflibercept injection for myopic choroidal neovascularization

CNV Pattern

No.

Age

Injection time

CFT

(mm)

BCVA

CNV area

(mm2)

CNV flow area

(mm2)

 

Time a

   

Pre

12 M ()

Pre

3 M ()

12 M ()

Pre

3 M ()

12 M()

Pre

3 M ()

12 M ()

Interlacing

1

48

1

302

193 (− 109)

1.48

0.7 (− 0.78)

0.7 (− 0.78)

0.701

0.656 (− 0.05)

0.406 (− 0.29)

0.296

0.407 (0.11)

0.267 (− 0.03)

Interlacing

2

58

1

271

238 (− 33)

0.7

0.4 (− 0.30)

0.4 (− 0.30)

0.402

0.336 (− 0.07)

0.259 (− 0.14)

0.266

0.265 (0.00)

0.228 (− 0.04)

Interlacing

3

20

2

305

211 (−94)

0.3

0.31 (0.01)

0.46 (0.16)

0.96

0.854 (−0.11)

0.739 (− 0.22)

0.782

0.658 (− 0.12)

0.610 (− 0.17)

Interlacing

4

24

1

355

249 (−106)

1.3

0.2 (−1.10)

0.05 (− 1.25)

0.641

0.245 (−0.40)

0.168 (−0.47)

0.389

0.13 (−0.26)

0.146 (− 0.24)

Interlacing

5

29

2

286

230 (−56)

0.5

0.16 (−0.34)

0.16 (−0.34)

0.484

0.202 (−0.28)

0.172 (− 0.31)

0.296

0.148 (− 0.15)

0.160 (− 0.14)

Interlacing

6

46

1

261

188 (−73)

0.5

0.2 (−0.30)

0.1 (−0.40)

0.846

0.668 (−0.18)

0.656 (− 0.19)

0.674

0.459 (− 0.22)

0.459 (− 0.22)

Disorganized

7

46

3

302

193 (−109)

1.48

0.7 (−0.78)

0.7 (−0.78)

0.061

0.034 (−0.03)

0.018 (− 0.04)

0.026

0.018 (− 0.01)

0.008 (− 0.02)

Disorganized

8

48

1

282

250 (−32)

0.7

0.16 (−0.54)

0.16 (−0.54)

0.119

0.088 (−0.03)

0.075 (− 0.04)

0.067

0.046 (− 0.02)

0.038 (− 0.03)

Disorganized

9

51

1

222

226 (4)

0.5

0.4 (−0.10)

0.4 (−0.10)

0.166

0.077 (−0.09)

0.054 (− 0.11)

0.131

0.054 (− 0.08)

0.047 (− 0.08)

Disorganized

10

62

2

362

407 (45)

1.78

0.5 (−1.28)

0.5 (−1.28)

0.161

0.097 (−0.06)

0.067 (−0.09)

0.136

0.071 (−0.07)

0.039 (− 0.10)

Disorganized

11

63

2

297

267 (−30)

0.4

0.3 (−0.10)

0.2 (−0.20)

0.077

0.06 (−0.02)

0.032 (− 0.05)

0.022

0.021 (− 0.00)

0.02 (− 0.002)

Disorganized

12

76

3

281

248 (−33)

1

0.16 (−0.84)

0.16 (−0.84)

0.088

0.053 (−0.04)

0.055 (− 0.03)

0.037

0.043 (0.01)

0.033 (−0.004)

  1. BCVA best-corrected visual acuity, CFT central foveal thickness, CNV choroidal neovascularization, logMAR logarithm of the minimum angle of resolution, M month, Pre Pre-treatment, () Changes compared with baseline before aflibercept treatment
  2. a 3 M: three months after aflibercept treatment; 12 M: twelve months after aflibercept treatment